Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients

SIMPLE SUMMARY: About 40 percent of all patients treated with curative intent for a primary sarcoma will experience relapse; therefore, most patients do not survive. Prior studies implementing adjuvant chemotherapy have failed to increase survival rate. To increase the survival of sarcoma patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggerholm-Pedersen, Ninna, Friis, Henriette Nymark, Baad-Hansen, Thomas, Møller, Holger Jon, Sandfeld-Paulsen, Birgitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000605/
https://www.ncbi.nlm.nih.gov/pubmed/36900335
http://dx.doi.org/10.3390/cancers15051544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000605/
https://www.ncbi.nlm.nih.gov/pubmed/36900335
http://dx.doi.org/10.3390/cancers15051544

Ejemplares similares